![Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery](https://html.scirp.org/file/3-8903008x2.png)
Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery
![Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the Ovary | JCO Oncology Practice Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the Ovary | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2023/op.2023.19.issue-3/op.22.00461/20230305/images/large/op.22.00461t2.jpeg)
Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the Ovary | JCO Oncology Practice
![Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer](https://www.spandidos-publications.com/article_images/mco/14/6/mco-14-06-02291-g01.jpg)
Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
![Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo](https://iv.iiarjournals.org/content/invivo/33/5/1521/F3.large.jpg)
Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo
![Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers | Scientific Reports Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-41706-z/MediaObjects/41598_2019_41706_Fig1_HTML.png)
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers | Scientific Reports
![Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study](https://www.ejso.com/cms/asset/f3e2f230-b13a-4aa6-91a7-9dc89ae7bf61/gr2.jpg)
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study
![IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer](https://www.mdpi.com/ijerph/ijerph-17-02213/article_deploy/html/images/ijerph-17-02213-g001-550.jpg)
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
![PDF] FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Semantic Scholar PDF] FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4298961a7b50fab41691cb1442f124159effd2fb/2-Table1-1.png)
PDF] FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Semantic Scholar
![Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/7acd71f0-ce88-4572-9317-2650c2de5b04/mfig002.jpg)
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials - du Bois - 2009 - Cancer - Wiley Online Library
![Table 2 from Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture | Semantic Scholar Table 2 from Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9606df0f465c41a87ca1c599295ca608317792c8/3-Table2-1.png)
Table 2 from Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture | Semantic Scholar
![Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02295-y/MediaObjects/12967_2020_2295_Fig1_HTML.png)